Can an antihistamine be given to a child under 2 years of age?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Antihistamines Be Given to Children Under 2 Years?

Second-generation antihistamines (cetirizine, desloratadine, fexofenadine, levocetirizine, loratadine) can be safely given to children under 2 years for allergic conditions, but first-generation antihistamines and OTC cough/cold combination products should be avoided due to significant toxicity risk.

Critical Distinction: Type of Antihistamine Matters

The answer depends entirely on which class of antihistamine you're considering:

First-Generation Antihistamines (AVOID)

  • Do NOT use first-generation antihistamines (diphenhydramine, brompheniramine, chlorpheniramine) in children under 2 years 1
  • Between 1969-2006, there were 69 fatalities associated with these three antihistamines in children ≤6 years, with 41 deaths occurring in children under 2 years 1
  • Deaths resulted from overdose, medication errors, use of multiple products simultaneously, and accidental exposures 1
  • Major manufacturers voluntarily removed OTC cough/cold products containing these antihistamines for children under 2 years in October 2007 1

Second-Generation Antihistamines (SAFE)

These ARE appropriate for children under 2 years:

  • Cetirizine, desloratadine, fexofenadine, levocetirizine, and loratadine have demonstrated excellent safety profiles in young children 1
  • Cetirizine is FDA-approved in the USA for children ≥6 months and in Europe for children ≥2 years 2
  • A randomized, double-blind, placebo-controlled study specifically documented cetirizine safety in infants 6-11 months, showing no CNS or cardiac adverse effects 3
  • Levocetirizine has been extensively studied in children as young as 6 months with no clinically relevant adverse effects on physical, psychomotor development, or laboratory parameters over 18 months 4

Clinical Application Algorithm

For allergic rhinitis or urticaria in children under 2 years:

  1. First-line: Use a second-generation antihistamine

    • Cetirizine 0.25 mg/kg twice daily (ages 6-11 months) 3
    • Follow age-specific dosing for other second-generation agents
  2. Avoid completely:

    • Any OTC cough/cold combination products
    • First-generation antihistamines (diphenhydramine, brompheniramine, chlorpheniramine)
    • Antihistamine-decongestant combinations 1
  3. For allergic rhinitis specifically:

    • Consider intranasal corticosteroids as more effective alternative (though administration may be challenging in this age group)

Critical Safety Considerations

Common pitfalls to avoid:

  • Never use multiple products simultaneously - this was a major cause of fatal overdoses 1
  • Do not use for common cold symptoms - antihistamines are ineffective for viral upper respiratory infections in young children and lack proven benefit 1, 5
  • Distinguish the indication: Second-generation antihistamines are appropriate for true allergic conditions (allergic rhinitis, urticaria), NOT for treating cough/cold symptoms 1, 5

Evidence Quality

The guideline evidence 1 from the Journal of Allergy and Clinical Immunology (2008) represents the highest-quality source, explicitly stating that second-generation antihistamines "have been shown to be well tolerated and to have a very good safety profile" in young children, while simultaneously documenting the mortality risk with first-generation agents. This is reinforced by dedicated pediatric safety studies 3 and recent reviews 5, 6.

The FDA currently does not recommend OTC cough and cold products containing antihistamines or decongestants in children under 2 years 5, but this applies to combination products and first-generation agents, not prescription second-generation antihistamines used for appropriate allergic indications.

References

Guideline

the diagnosis and management of rhinitis: an updated practice parameter.

Journal of Allergy and Clinical Immunology, 2008

Research

Cetirizine use in childhood: an update of a friendly 30-year drug.

Clinical and molecular allergy : CMA, 2020

Research

The Use and Safety of Cough and Cold Medications in the Pediatric Population.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 2025

Research

Antihistamines: ABC for the pediatricians.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.